Vinca alkaloid-resistant phenotype in cultured human leukemic lymphoblasts.
about
Comparison of ion channels in multidrug-resistant and -sensitive human leukemic cells.Human immunodeficiency virus protease inhibitors serve as substrates for multidrug transporter proteins MDR1 and MRP1 but retain antiviral efficacy in cell lines expressing these transportersA 22-kd protein (sorcin/V19) encoded by an amplified gene in multidrug-resistant cells, is homologous to the calcium-binding light chain of calpain.Essential features of the P-glycoprotein pharmacophore as defined by a series of reserpine analogs that modulate multidrug resistance.Frequencies of independent and simultaneous selection of Chinese hamster cells for methotrexate and doxorubicin (adriamycin) resistanceDerivation and preliminary characterisation of adriamycin resistant lines of human lung cancer cells.Circumvention of drug resistance in human non-small cell lung cancer in vitro by verapamilCross resistance pattern towards anticancer drugs of a human carcinoma multidrug-resistant cell line.Similar biochemical changes associated with multidrug resistance in human breast cancer cells and carcinogen-induced resistance to xenobiotics in rats.Amplification of DNA sequences in human multidrug-resistant KB carcinoma cells.Cyclosporin A reverses vincristine and daunorubicin resistance in acute lymphatic leukemia in vitroResistance of human glioma to adriamycin in vitro: the role of membrane transport and its circumvention with verapamil.Cyclosporin A corrects daunorubicin resistance in Ehrlich ascites carcinoma.Cross-resistance to cytotoxic drugs in human glioma cell lines in culture.Resistance to the antimitotic drug estramustine is distinct from the multidrug resistant phenotype.
P2860
Q33561541-0E2198A0-E4C1-4390-9D49-6935278F716BQ33703178-91D3ACB1-FC1F-4E74-8874-CD2B5F24BC6BQ33880965-DBD6A95C-B15E-44BC-BC8C-EBAFBA80703CQ34287731-A120E470-E79C-49CA-AE37-D6C12F1D7284Q34381440-67D17213-311D-49B7-9921-4BD27105EC59Q36027230-9E56C92E-A777-42E2-A8CB-E3C0E013AC56Q36028341-526F15D1-4D30-4AA1-984B-718E927C5E34Q36466678-05C4BEC2-A898-4E22-95B3-0F422963F9DAQ37410742-8D997FB8-4818-4819-ABBB-EB7E91DC2924Q37555261-DFC41104-7F29-43B9-AFDF-7EBFBE1C40AEQ40922557-954F3131-137A-4CB8-B1E6-A83B8B75AD48Q41142431-B6DEE5A3-8891-434F-AC40-4A5F307F7179Q41144143-1F19A170-7425-496E-A5AD-E766EC3AF6F5Q41913759-D0CF182C-2E82-4CB3-96CC-D62367BDF265Q42145344-676E100B-6EDF-4C31-9542-0C5090C71AF5
P2860
Vinca alkaloid-resistant phenotype in cultured human leukemic lymphoblasts.
description
1983 nî lūn-bûn
@nan
1983年の論文
@ja
1983年論文
@yue
1983年論文
@zh-hant
1983年論文
@zh-hk
1983年論文
@zh-mo
1983年論文
@zh-tw
1983年论文
@wuu
1983年论文
@zh
1983年论文
@zh-cn
name
Vinca alkaloid-resistant phenotype in cultured human leukemic lymphoblasts.
@en
type
label
Vinca alkaloid-resistant phenotype in cultured human leukemic lymphoblasts.
@en
prefLabel
Vinca alkaloid-resistant phenotype in cultured human leukemic lymphoblasts.
@en
P1476
Vinca alkaloid-resistant phenotype in cultured human leukemic lymphoblasts.
@en
P2093
P304
P577
1983-10-01T00:00:00Z